Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001437749-24-035410
Filing Date
2024-11-15
Accepted
2024-11-15 06:06:16
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 pbla20241114_424b3.htm 424B3 775742
2 pbla20241114_424b3img001.jpg GRAPHIC 5179
  Complete submission text file 0001437749-24-035410.txt   784306
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

EIN.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-239661 | Film No.: 241465743
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)